Splash Beverage shares surge 16.57% premarket after signing LOI to merge with hemp and CBD operator Medterra.

Splash Beverage Group surged 16.57% in premarket trading following the announcement of a proposed merger with Medterra CBD, a leading hemp and CBD operator. The non-binding letter of intent outlines a strategic re-alignment positioning Splash as a public cannabinoid wellness platform, leveraging Medterra’s $52 million in 2025 revenue and established compliance infrastructure. The transaction aligns with anticipated regulatory clarity in the U.S. hemp and CBD sector, including a potential CMS pilot initiative for federally compliant CBD products. Management highlighted the opportunity to access reimbursement frameworks and scale operations through public market resources, signaling long-term growth potential in a sector projected to exceed $30 billion. The merger’s focus on disciplined expansion and regulatory compliance reinforced investor optimism about Splash’s pivot into the cannabinoid wellness industry.